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A B S T R A C T
Background: As the prevalence of heart failure (HF) rises sharply, the costs related to the
care of these patients increases in parallel. Considering the already limited resources and
manpower, in the future the demand for care may exceed the supply. Therefore, health
care systems are encouraged to develop innovative strategies to deal with the burden of HF
to improve the quality of care in order to medical outcomes and patients’ quality of life. For
that reason new management systems – such as telemonitoring – have to be explored.
Objectives: This paper outlines the study protocol of a tailor-made telemonitoring
program in ambulant patients with HF.
Design and methods: A prospective randomised controlled trial is carried out at 3 hospitals
in the South-Limburg area in the Netherlands. Primary outcome measures are hospital
admissions and cost-effectiveness. Secondary outcomes are effects on therapy com-
pliance, level of disease specific knowledge and quality of life. Also determinants are
studied of most and less benefited patients in the intervention group.
Power calculation: It is estimated that 390 patients have to be included in the study, with
185 in each arm.
Results: Inclusion started in September 2007 with a follow-up time of 12 months. First
results are expected at the end of 2010.
 2010 Elsevier Ltd. All rights reserved.
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on-adherence resulting in increased hospitalisations is
common in patients with HF.
 Telemonitoring is one of the recently developed as part of
chronic care management systems in patients with HF;
however randomised controlled trials are lacking to
proof its (cost-) effectiveness.* Corresponding author at: University Maastricht, Department of
ealth Care and Life Sciences, P.O. Box 616, Universiteitssingel 40,
200 MD Maastricht, Limburg, The Netherlands. Tel.: +31 433875392.
E-mail address: j.boyne@zw.unimaas.nl (Josiane J.J. Boyne).
20-7489/$ – see front matter  2010 Elsevier Ltd. All rights reserved.
oi:10.1016/j.ijnurstu.2010.05.017 The majority of the telemonitoring systems focuses on
vital signs such as blood pressure, rate control and
weight.
What this paper adds This paper presents a study of the value of a tele-
monitoring system, using a randomised controlled trial
design.
 It focuses on education, adherence and self-management
as a means to reduce symptoms or detect those at an
early stage, rather than monitoring just vital signs using
communication programs, tailored to the patients needs.
 To better meet with the specific patient needs, four
telemonitoring programs were designed with different
Table 1
Study design.
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and symptoms respectively.
1. Background
The most effective strategies to control chronic diseases
contain multiple components as recommended by the
European Society Guidelines (Dickstein et al., 2008;
Coleman et al., 2009). Of these components, the most
challenging is patient education (McAlister et al., 2004; Yu
et al., 2006). Patient education is based on the assumption
that giving information results in knowledge and skills
gain. The majority of studies shows positive influences on
the outcome of HF patients, although it is not clear which
information is best for which patient (Yu et al., 2006).
Although the body of educational programs for heart
failure patients is extensive (Dickstein et al., 2008),
knowledge is limited how these methods match with
the patients needs. Moreover, the majority of patients with
HF is 65 years of age or older, being a possible challenge for
education programs to be effective (Yu et al., 2006). Co-
morbidities such as diabetes, chronic lung and renal
failure, peripheral atherosclerosis, depression and/or
personality disorders are additional hurdles for patients
to deal with (new) information and about how to deal best
with health issues (Sloan and Pressler, 2009; Braunstein
et al., 2003).
Patient education is an important component in the
management of HF and should be provided through
effective and well-evaluated integrated care strategies.
HF education can further be improved by combining oral or
written communication with new technologies such as
telemonitoring (TM) (Strömberg, 2005). Trying to make
TM applications generalizable to the HF population at
large, may often fail to meet particular patient needs.
Therefore subpopulations have been suggested to be
categorized based on variables such as age, gender, specific
medical problems, chronic disease, or cultural aspects and
accordingly education should be adjusted to these
categories (Alverson et al., 2008).
This article describes the design of a randomized
controlled trial aiming at evaluating a TM system the
Health Buddy1 in HF patients, using tailor-made TM
programs for patients with HF as the intervention, the
TEHAF study. The development of the tailor-made program
is based on the experience with the Health Buddy1 in a
preceding pilot study in the participating centres of
Heerlen (Atrium Medical Centre), Maastricht (University
Medical Centre) and Sittard (Orbis Medical and Care
Concern), situated in the South-Limburg, the Netherlands
(Boyne et al., 2008).
2. Methods
2.1. Study population
Eligible for inclusion are patients with chronic HF New
York Heart Association (NYHA) classes II–IV treated by a
cardiologist and in care of a HF nurse (HFN). Selection of
patients occurs in the outpatient clinic from one of the
participating centres and in the home situation whenpatients are visited by a HFN. Patients are excluded if
being unable to give informed consent, have visual
limitations, hard of hearing in combination with living
as a single person, did not have command of the Dutch
language, were planned for a hospital admission within 3
months and/or suffer from chronically obstructive pul-
monary disease, Parkinson’s disease, extracorporeal
dialysis, (pre)dementia or another disease with a expect-
edly shortened life span.
2.2. Study design
A prospective, randomised controlled trial is conducted
with a follow-up period of 12 months. Cardiologists and
HFN select patients with HF, whereas the research nurses
contact the patient in case of eligibility. After given
informed consent, patients are randomised by a dedicated
software system (SPSS 15.0) either to the control group,
receiving usual care according the European guidelines or
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Before start of the intervention (T0) patients fill out a
questionnaire. Patient’s baseline characteristics are
retrieved from the medical chart. Follow-up question-
naires are released after 3, 6, 9 and 12 months (Table 1).
2.3. Study hypotheses
The hypotheses are tested that the admission rate for
HF is lower in the intervention group than in the control
group and that TM is cost-effective compared with usual
care.
2.4. Primary objective
The primary objectives are to study the effectiveness of
the Health Buddy1 in terms of hospital admissions for HF
and cost-effectiveness, as expressed in costs per quality
adjusted life years (QALY’s). Also quality of care is studied,
comprising mortality, planned and unplanned HF related
contacts with caregivers.
2.5. Secondary objectives
Secondary objectives are:(1) toTab
Thestudy outcomes in terms of therapy adherence, level
of disease specific knowledge and quality of life;(2) to demonstrate patient determinants affecting the out-
comes of the Health Buddy1 in terms of care consump-
tion, level of knowledge and adherence.
3. Intervention
3.1. The Health Buddy1
The Health Buddy1 is an easy-to-use device with a
liquid crystal display screen and four buttons to answer
questions provided in daily dialogues. The responses tole 2
Health Buddy1 system.the dialogues are sent to a protected server and
successively to the caregivers’ i-Care desktop (Table 2).
Patients’ responses to the dialogues are transferred into
risk profiles (low, medium or high) and ordered accord-
ing to risk level. Consequently, care providers are able to
quickly select high-risk patients and anticipate to their
problem. The involved care providers consist of specia-
lized HFNs, a nurse assistant and a supervising cardiol-
ogist. The HFNs are highly educated in chronic heart
failure at the level of an advanced medical student, and
are very experienced regarding HF care. The nurse
assistant is a caregiver at a lower educational nursing
level being instructed before and coached by a HFN
during the study.
The original English content of the Health Buddy1 was
translated into Dutch by the distributing company
(Sananet) and adapted to the Dutch health care situation
and European guidelines (Dickstein et al., 2008) by a
cardiologist (AG) and a HF nurse practitioner (JB). Sananet
was responsible for the final layout whereas the health
care providers were finally responsible for the content.
3.2. Content of the program
The content of the Health Buddy1 covers scheduled
dialogues about three domains: symptoms, knowledge and
behaviour respectively. The total amount of dialogues
counts 145 different combinations, yet the combination of
dialogues changes day by day. The questions are answered
by selecting one of the four keys. If the answer is correct,
this is confirmed by the system, whereas in case of an
incorrect response, the right answer is provided. In this
way knowledge increases both by correcting and by
repetition of dialogues.
In case of repeated mistakes after 3 months, the nurse
assistant will contact the patient and explain the
misunderstood issues. Patients at high risk for symptoms
will always be approached by a HFN since the start of the
program.
Table 3
Characteristics of the programs.
Symptoms Education/adherence Days
Program 1 + + 90
Program 2 + +/ 30
Program 3  + 90
Program 4   180
+: Strongly focused on; +/: moderate focused on;  less focused on.
Program1: contains a high level of monitoring symptoms and a high level
of education: at the start all patients are allocated at this program.
Program 2: contains a high level of monitoring symptoms and a lower
level of education: patients allocated at this program are indicated for
intensive monitoring because of severe heart failure or many complaints.
Their disease specific education level allows a less intensive education
program. Program 3: contains a low level of monitoring symptoms and a
high level of education: patients with few complaints and a low disease
specific education level are allocated to this program. Program 4: contains
a low level of monitoring symptoms and a low level of education: patients
with few complaints and a high level of disease specific education are
allocated to this program.
J.J.J. Boyne et al. / International Journal of Nursing Studies 48 (2011) 94–99 973.3. The tailor-made aspects of the content
Primarily the goal of the foregoing feasibility study was
to study whether patients were able to handle a TM
system, and secondly that the provided information was
sufficient for care providers to monitor patients at a
distance. Focused interviews with patients and HFNs
showed a high satisfaction with the system, but a need was
felt for more flexibility of the content, regarding the
emphasis of monitoring in relation to knowledge and
behaviour or to symptoms (Boyne et al., 2008). Because no
such differentiated TM contents were available, self-
designed combinations of dialogues were used for that
purpose. The first step to tailor the content was the
assessment of distinguishing characteristics in HF patients,
regarding symptoms, level of disease specific knowledgeTable 4
Program allocation criteria.and behaviour (Van der Wal et al., 2006; Miller-Davis et al.,
2006). Out of a combination of these characteristics four
programs are constructed. The main difference between
the programs is more or less emphasis on symptoms or
education. The duration of the programs differs from 30
to180 days (Table 3). During the first 90 days all patients
receive the same program. At the last day of each program
a calculation is made about the number of high risk labels
in the last 30 days. The result of this calculation indicates
the allocation to the next program (Table 4).
Always the decision is made about allocation to a next
level program as described in Table 4, except for two
situations. The first situation is after a HF admission: then
always allocation to program 2 is done for the duration of
30 days, independent of the preceding program before
admission. The second exception regards patients waiting
for a heart transplantation; they are always allocated to
program 2.
Another way to tailor the program, additional to the
before mentioned programs, is the possibility to switch off
parts of the content. This can be used in case specific
information is not applicable for a certain patient, such as
information about nitro-glycerine, beta-blocker, ACE-
inhibitors, ARB antagonists, potassium saving diuretics
and digitalis.
3.4. Procedure
Patients complete the daily dialogs on a self-selected
moment. The pilot study showed that depending on the
answers, the time to complete the dialogues varies
between 3 and 10 min. The Health Buddy1 gives an option
to review the dialogues at the end of the session. The HFN
and nurse assistant check the dialogues on a daily basis




Cardiovascular hospitalisation/death 12 months
Comorbidity 12 months
Self-care Baseline, 3, 6, 9, 12 months
Compliance Baseline, 3, 6, 9, 12 months
Dyspnea/tiredeness Baseline, 3, 6, 9, 12 months
Depression Baseline, 3, 6, 12 months
Self-efficacy Baseline, 3, 6, 12 months
Disease specific quality of life Baseline, 3, 6, 12 months
Quality of live (costs) Baseline, 3, 6, 12 months
Disease specific knowledge Baseline, 3, 6, 9, 12 months
Personal individual characteristics Baseline
Classification of heart failure Baseline, 12 months
Costs Baseline, 3, 6, 9, 12 months
J.J.J. Boyne et al. / International Journal of Nursing Studies 48 (2011) 94–9998patient was previously found to be 2 min and 20 s/day
including both checking the dialogues and the related
actions (Boyne et al., 2008).
Patients, spouse or family member in the intervention
as well as in the control group receive verbal and written
information according to the European Guidelines (Dick-
stein et al., 2008). Patients are instructed about signs and
symptoms of HF, self-management as actively seeking help
in case of progressive dyspnoea, weight gain and oedema,
importance of medical and non-medical therapy compli-
ance, salt and fluid restriction, importance of physical
activity and other, more patient tailored information.
Instructions were given for seeking help outside the office
hours. The information supplied by the TM system is
additional to the usual care information.
For the intervention group 2 face-to-face contacts per
year were scheduled consisting of one to the cardiologist
and another one to the HFN. Telephone contacts with the
HFN or nurse assistant in response to a Health Buddy1
alert, were considered as planned contacts. Patients
assigned to the control group were planned to have 4
visits, including 1 to the cardiologist and 3 to the HFN
(Table 1). Unscheduled contacts with a care provider were
allowed at any time for both patient groups. In two of the
participating centres, depending on patients’ mobility,
contacts with the HFN took place either in the outpatient
clinic or by a home visit.
4. Study measures
4.1. Instrumentation
All patients are asked to fill out an extensive
questionnaire at baseline (T0), after 3, 6 and 9 months
and after the follow-up period of 1 year (T12). Information
is gathered about prescription of medication, medical
history and socio-demographics. Measurement of quality
of life occurs by means of Kansas City Cardiomyopathy
Questionnaire (KCCQ) (Green et al., 2000) and the EQ 5D
(Brooks et al., 2003), disease specific knowledge by the
Dutch Heart Failure Knowledge Score (DHFKSc) (Van der
Wal et al., 2005) and self-management by the European
Self Care Behaviour Scale (ESCBSc) (Jaarsma et al., 2003).
Adherence for pharmacological and non-pharmacological
prescriptions and depression are measured by respectively
the Heart Failure Compliance Questionnaire (HFCQ)
(Evangelista et al., 2001) and the Hospital Anxiety and
Depression Scale (HADS) (Zigmond and Snaith, 1983).
Dyspnea and tiredness are assessed by the Borg scale (Borg,
1982), self-efficacy by the Barnason Efficacy Expectation
Scale (Barnason et al., 2002) and personal individual
characteristics by the DS-14 (Denollet, 2005). Care
consumption and mortality are based on hospital regis-
tration, costs by hospital registration and a cost-diary filled
out by the patients. Comorbidity is assessed by the
Charlson index (D’Hoore et al., 1996) (Table 5).
4.2. Power
A sample size of 188 patients in both arms was
calculated, based on a minimum reduction of 38% and amaximum reduction of 48% for hospitalisation for heart
failure (Boyne et al., 2008; Bondmass et al., 2001;
Macropoulos and Knoop, 2003), using an alpha of 0.05
and a power of 0.80. To compensate for non-evaluable
patients, we planned to enroll 10% more patients for both
groups. Therefore, a total of 390 patients will enroll into
the study.
4.3. Statistical analysis
Data will be analysed according to the intention-to-
treat principle, using SPSS statistical software (SPSS 15.0).
Stratified data analysis per centre will be performed. The
primary objective, number of admissions for heart failure
will be evaluated by the Kaplan Meier survival analysis.
Categorical variables will be presented as the observed
number and percentage, whereas the continuous variables
will be reported as the mean standard deviation. Differ-
ences for continuous variables will be tested with the
independent t-test. Further multivariate techniques will be
used to adjust for possible differences in baseline
characteristics and scores. Comparison of observations
between the groups, considering the different locations
will be analyzed by the MAN(C)OVA test for repeated
measures. The P-value of <0.05 will be considered as
statistically significant.
4.4. Clinical endpoint
An independent panel, consisting of an independent HF
cardiologist (chairman), geriatrist and nephrologist, is
compiled to adjudicate whether hospitalization and/or
death is related to HF in terms of this protocol. The
committee is blinded to study arm assignment, and
members independently review each case in order to
classify a HF related admission or death. The independent
opinions are reconciled at a panel meeting. In case of
lacking unanimity, the case is discussed during the
meeting with the aim to develop consensus. By unremit-
ting non-unanimity the endpoint will be established by the
chairman.
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